CytoDyn Acquisitions
CytoDyn has acquired 1 company and its latest acquisition was Prostagene, LLC on Jul 2018
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Prostagene, LLC
Jul 2018
Source »$15.4M
ProstaGene develops diagnostic tools and novel therapies for the treatment of prostate cancer.